Fabry Disease Clinical Severity Score

Score organ involvement in Fabry disease (alpha-galactosidase A deficiency) across cardiac, renal, neurological, and cerebrovascular domains to guide enzyme replacement therapy initiation and monitoring.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Score organ involvement in Fabry disease (alpha-galactosidase A deficiency) across cardiac, renal, neurological, and cerebrovascular domains to guide enzyme replacement therapy initiation and monitoring

Each component has a specific meaning:

  • Cardiac — The cardiac recorded for the scenario being assessed.
  • Renal — The renal recorded for the scenario being assessed.
  • Neurological — The neurological recorded for the scenario being assessed.
  • Cerebrovascular domains — The cerebrovascular domains recorded for the scenario being assessed.

Note: Interpret the fabry severity result against the thresholds and context described above.

How to Use

Enter the cardiac, renal, neurological, cerebrovascular domains for the scenario you are assessing. Score organ involvement in Fabry disease (alpha-galactosidase A deficiency) across cardiac, renal, neurological, and cerebrovascular domains to guide enzyme replacement therapy initiation and monitoring. Use the fabry severity result to inform your calculation.

Frequently Asked Questions